Search

Your search keyword '"Kulozik, Andreas"' showing total 1,357 results

Search Constraints

Start Over You searched for: Author "Kulozik, Andreas" Remove constraint Author: "Kulozik, Andreas"
1,357 results on '"Kulozik, Andreas"'

Search Results

2. Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma

3. Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trial

5. Functional analysis of structural variants in single cells using Strand-seq

6. Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial

7. Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group

8. Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding

9. Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution

10. Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL

12. The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/β‐thalassaemia and no or low HbA expression

13. DNA methylation-based classification of central nervous system tumours.

14. Anämien

15. Erythrozyten: physiologische Besonderheiten im Kindesalter

19. Funktionsstörungen des Hämoglobins und Polyzythämie

20. Sustained Efficacy and Safety in Adult and Pediatric Patients with Transfusion-Dependent β-Thalassemia up to 9 Years Post Treatment with Betibeglogene Autotemcel (Beti-cel)

21. Betibeglogene Autotemcel Gene Therapy in Patients with Transfusion-Dependent, Severe Genotype β‑Thalassaemia: Results from the HGB-212 (Northstar-3) Study

23. Single-cell analysis of structural variations and complex rearrangements with tri-channel processing

24. Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma

25. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups

26. Sarcoma classification by DNA methylation profiling

27. Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition

33. PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107

34. P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL)

35. Bone marrow failure unresponsive to bone marrow transplant is caused by mutations in thrombopoietin

37. Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia

39. Chromatin accessibility landscape of pediatric T‐lymphoblastic leukemia and human T‐cell precursors

43. Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial

44. Hypersensitivity Reactions to Native E. coli L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction

45. Supplementary Figure 5 from Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia

46. Supplementary Figure 8 from Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia

47. Supplementary Figure 1 from Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia

48. Supplementary Figure 9 from Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia

49. Supplementary Tables from Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia

50. Supplementary Figure 7 from Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia

Catalog

Books, media, physical & digital resources